A patient decision aid for systemic lupus erythematosus improves shared decision-making and patient-provider communication in ...

In a new study, researchers found people with clinically active systemic lupus erythematosus (SLE) disease on standard of ...

Lupus is a “classic” autoimmune disease. It causes the immune system’s first-line viral defenses, known as interferons, to attack the body. Nearly every organ is at risk, leading to conditions like ...

Singer Selena Gomez's lupus-related arthritis diagnosis sheds light on how up to 90% of lupus patients experience joint pain, ...

A novel drug for systemic lupus erythematosus (SLE) first developed in China, and approved there since 2021, did well enough in a new placebo-controlled phase III trial that approval in Western ...

Please provide your email address to receive an email when new articles are posted on . Calabrese additionally discussed the recent proliferation of data and updates regarding lupus, including a ...

A new study finds that EULAR/ACR criteria identify more systemic lupus erythematosus cases among patients with interstitial ...

CAR cell therapy is a new type of therapy that has been used in cancer and is now in development for potential treatment of lupus and other autoimmune diseases. CAR cell therapies carry a modified ...

Sustained clinical remission for at least 3 years in patients with systemic lupus erythematosus (SLE) and active lupus nephritis significantly reduced the probability of developing impaired kidney ...